CytomX Therapeutics (CTMX) Insider Trading & Ownership $0.71 -0.06 (-7.29%) As of 01:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CytomX Therapeutics (NASDAQ:CTMX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$72,645.69 Get CTMX Insider Trade Alerts Want to know when executives and insiders are buying or selling CytomX Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CTMX Insider Buying and Selling by Quarter CytomX Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/18/2025Christopher OgdenCFOSell8,551$0.60$5,130.60 3/18/2025Lloyd A RowlandGeneral CounselSell10,203$0.60$6,121.80 3/18/2025Marcia BelvinSVPSell19,512$0.60$11,707.20 3/18/2025Sean A MccarthyCEOSell37,656$0.60$22,593.60 3/18/2025Yu-Waye ChuInsiderSell4,025$0.60$2,415.00 8/20/2024Christopher OgdenCFOSell1,984$1.23$2,440.32 8/20/2024Jeffrey B LandauInsiderSell4,181$1.23$5,142.63 8/20/2024Sean A MccarthyCEOSell13,898$1.23$17,094.54 (Data available from 1/1/2013 forward) CTMX Insider Trading Activity - Frequently Asked Questions Who is on CytomX Therapeutics's Insider Roster? The list of insiders at CytomX Therapeutics includes Amy C Peterson, Carlos Campoy, Christopher Ogden, Elaine V Jones, Jeffrey B Landau, Lloyd A Rowland, Marcia Belvin, Sean A Mccarthy, and Yu-Waye Chu. Learn more on insiders at CTMX. What percentage of CytomX Therapeutics stock is owned by insiders? 7.00% of CytomX Therapeutics stock is owned by insiders. Learn more on CTMX's insider holdings. Which CytomX Therapeutics insiders have been selling company stock? The following insiders have sold CTMX shares in the last 24 months: Christopher Ogden ($13,780.31), Jeffrey B Landau ($18,857.21), Lloyd A Rowland ($24,263.72), Marcia Belvin ($22,688.16), Sean A Mccarthy ($119,635.89), and Yu-Waye Chu ($2,415.00). How much insider selling is happening at CytomX Therapeutics? Insiders have sold a total of 176,868 CytomX Therapeutics shares in the last 24 months for a total of $201,640.29 sold. CytomX Therapeutics Key ExecutivesDr. Sean A. McCarthy DPHIL (Age 57)Chairman & CEO Compensation: $1.03M More Insider Trading Tools from MarketBeat Related Companies biote Insider Buying Cardiff Oncology Insider Buying Gossamer Bio Insider Buying Design Therapeutics Insider Buying Tevogen Bio Insider Buying TuHURA Biosciences Insider Buying LifeVantage Insider Buying Voyager Therapeutics Insider Buying Prime Medicine Insider Buying INmune Bio Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NASDAQ:CTMX) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytomX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytomX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTMX Stock Free CTMX Stock Alerts